SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

62.7662681

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

11.77

101.91

EPS(TTM)

Face Value()

Div & Yield %

5.44

1.87

Back

Bal Pharma consolidated net profit rises 270.83% in the December 2025 quarter

Feb 12,2026

Net profit of Bal Pharma rose 270.83% to Rs 1.78 crore in the quarter ended December 2025 as against Rs 0.48 crore during the previous quarter ended December 2024. Sales rose 19.88% to Rs 87.69 crore in the quarter ended December 2025 as against Rs 73.15 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	87.69	73.15	20
OPM %	10.88	10.59	-
PBDT	5.02	3.25	54
PBT	1.79	0.57	214
NP	1.78	0.48	271

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)